Un syndrome hématopulmonaire bien silencieu...
P. Arlet(Hôpital Rangueil), H. Juchet(Hôpital Rangueil), C. Dingremont(Hôpital Rangueil), Pierre Brousset, J Giron(Hôpital Rangueil), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole)
Cited by 0
Related Papers
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
|Nature Medicine|2024|109
Acute interstitial nephritis related to immune checkpoint inhibitors
|British Journal of Cancer|2016|103